Study type

Study topic

Human medicinal product

Study type

Non-interventional study

Scope of the study

Effectiveness study (incl. comparative)

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Other

Non-interventional study design, other

Survey Questionnaire
Study drug and medical condition

Study drug International non-proprietary name (INN) or common name

DARATUMUMAB
Population studied

Short description of the study population

Health Care Professionals and blood transfusion management department personnel who have received educational materials related to daratumumab blood transfusion management.

Age groups

  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)

Estimated number of subjects

803
Study design details

Main study objective

The objective of this survey is to determine the effectiveness of the educational materials related to daratumumab blood transfusion management.

Data analysis plan

Data Collecting and Sample:The sampling units are HCPs associated with transfusion departments and non-transfusion HCPs who work closely with daratumumab administration in targeted countries. They will be sampled among lists of haematologists, oncologists, hospital pharmacists and nurses and other specialties. QuintilesIMS will check in its databases to obtain information. HCPs will be randomly selected from the list.Statistical Analysis:The statistical analysis of the data will be carried out using the software SAS® environment Windows™ V9.4 (SAS Institute, North Carolina, USA).Quantitative variables will be described by the usual statistics: staffing (number of knowledgeable data, number of missing values), average, standard deviation, median, minimum, maximum, 1st and 3rd quartiles